Results 121 to 130 of about 73,615 (295)

Metabolic Syndrome Screening in Seriously Mentally Ill Patients: A Quality Improvement Project [PDF]

, 2016
A Project Submitted in Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE in Nursing ScienceSeriously mentally ill patients who are taking second-generation antipsychotics have a high risk of metabolic complications ...
Moreno, Annabel
core  

Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Fabienne Ory‐Magne, Jean Luc Houeto, Margherita Fabbri   +2 more
wiley   +1 more source

Suicide Deaths in People With Bipolar Disorder: Characteristics and Treatments at Time of Death

Bipolar Disorders, EarlyView.
ABSTRACT Objectives This study aimed to compare suicide deaths in those with or without bipolar disorder (BD), taking into particular consideration the degree to which treatment at the time of death, according to toxicology data, reflects evidence‐based pharmacotherapy.
Ayal Schaffer, Prudence Po Ming Chan, Vera Yu Men, Rosalie Steinberg, Rachel HB. Mitchell, Gin Malhi, Lakshmi N. Yatham, Mark Sinyor   +7 more
wiley   +1 more source

Clozapine in the management of schizophrenia. Risperidone is less toxic but equally effective. [PDF]

, 1993
David B Menkes
openalex   +1 more source

Understanding excessive sleep in people with psychotic disorders

British Journal of Clinical Psychology, EarlyView.
Abstract Background There has been increasing attention to sleep disturbances such as insomnia in psychosis, due to its impact on symptoms, well‐being, and recovery. However, excessive sleep and extended sleep duration are common in psychosis (partly linked to sedating antipsychotic medication) and have been relatively neglected, despite plausible ...
Kate Robbins, Joanne Hodgekins, Sarah Reeve   +2 more
wiley   +1 more source

Correction: Clozapine, a Novel Antipsychotic Agent [PDF]

, 1994
Olga Delgado Sánchez, M. Carmen Fernández‐Santaella   +1 more
openalex   +1 more source

The fast‐dissociating D2 antagonist antipsychotic JNJ‐37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Pharmacological activation of neuronal M‐current mediated by Kv7 (Kv7.2–5) potassium channels is a validated mechanism for epilepsy treatment. However, since the market withdrawal of the prototype Kv7 activator retigabine, no Kv7 activator is clinically available for this condition.
Lidia Carotenuto, Oliver Keminer, Giusy Carleo, Andrea Zaliani, Antonio Leo, Rita Citraro, Giovambattista De Sarro, Nina Dirkx, Marcus Kaji, Sarah Weckhuysen, Jeanette Reinshagen, Vincenzo Barrese, Natascia Guida, Carmine Ostacolo, Francesco Miceli, Philip Gribbon, Maurizio Taglialatela   +16 more
wiley   +1 more source

Case series and Literature review – Clozapine Induced Transient Myocarditis. Clinical characteristics and outcomes

European Psychiatry
Introduction Clozapine is a second-generation atypical antipsychotic medication used in patients with treatment-refractory schizophrenia. Its use is limited due to its associated adverse effects, including myocarditis.
U. L. Anyeji, P. Bidkhanian
doaj   +1 more source

Use of clozapine [PDF]

, 1991
Michael S. Jorsh
openalex   +1 more source

GPi‐DBS for SERAC1‐Related Dystonia‐Parkinsonism

Movement Disorders Clinical Practice, EarlyView.
Vidal Yahya, Alessandro Di Maio, Mauro Treddenti, Ludovica Tundo, Giulia Scacciatella, Costanza Masetti, Marta Pengo, Chiara Casellato, Desiree Lattanzi, Marcello Egidi, Sara Marceglia, Tommaso Bocci, Alberto Priori, Gaia Oggioni   +13 more
wiley   +1 more source